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In Alzheimer Disease (AD), non-verbal skills often remain intact for far longer than
verbally mediated processes. Four (1 female, 3 males) participants with early-stage
Clinically Diagnosed Dementia of the Alzheimer Type (CDDAT) and eight neurotypicals
(NTs; 4 females, 4 males) completed the emotional valence determination test (EVDT)
while undergoing BOLD functional magnetic resonance imaging (fMRI). We expected
CDDAT participants to perform just as well as NTs on the EVDT, and to display
increased activity within the bilateral amygdala and right anterior cingulate cortex
(r-ACC). We hypothesized that such activity would reflect an increased reliance on
these structures to compensate for on-going neuronal loss in frontoparietal regions due
to the disease. We used diffusion tensor imaging (DTI) to determine if white matter
(WM) damage had occurred in frontoparietal regions as well. CDDAT participants had
similar behavioral performance and no differences were observed in brain activity or
connectivity patterns within the amygdalae or r-ACC. Decreased fractional anisotropy
(FA) values were noted, however, for the bilateral superior longitudinal fasciculi and
posterior cingulate cortex (PCC). We interpret these findings to suggest that emotional
valence determination and non-verbal skill sets are largely intact at this stage of
the disease, but signs foreshadowing future decline were revealed by possible WM
deterioration. Understanding how non-verbal skill sets are altered, while remaining
largely intact, offers new insights into how non-verbal communication may be more
successfully implemented in the care of AD patients and highlights the potential role of
DTI as a presymptomatic biomarker.
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INTRODUCTION
Alzheimer disease (AD) is marked by a progressive decline
in cognitive functions. As this occurs, the affected individual
becomes less capable of understanding the world around them.
This occurs in part due to a loss of ability to interpret the
body language and facial expressions of others. Face-processing
represents a group of complex cognitive operations in which
information is extracted from facial features in such a way that
the observer is able to perceive pertinent information about the
person they are viewing. Previous studies of moderate-stage AD
patients showed that their ability to interpret basic emotional
cues from faces is largely intact (Roudier et al., 1998; Luzzi et al.,
2007). However, dysfunctions are detectable (Albert et al., 1991;
Cadieux and Greve, 1997; Hargrave et al., 2002). Luzzi et al.
(2007) showed that the ability to interpret emotional cues directly
correlated to participants’ performance on constructional praxis
and visuospatial memory tasks, which are examples of non-
verbally-mediated skills, in early-moderate-stage AD.
These findings, combined with the observation that stroke
participants’ performance on certain visuospatial tests correlates
with the degree of localization of damage to the right parietal lobe
(Luzzi et al., 1998), suggest that activity of the right parietal lobe is
directly related to the interpretation of emotional cues. This
concurs with both the current clinical and pathological picture of
AD, which shows that non-verbal memory loss, as well as damage
to the right parietal lobe, is a late-stage finding (Braak et al., 2006;
Ally et al., 2009).
We attempted to correlate the non-verbal skills of participants
with early-stage Clinically Diagnosed Dementia of the Alzheimer
Type (CDDAT) with findings from both functional magnetic
resonance imaging (fMRI) and diffusion tensor imaging (DTI)
measures during a non-verbally mediated face-processing
task. Participants underwent a well-established, standardized,
non-verbal skill test (the Rey-Osterrieth Complex figure B,
visuospatial memory test (ROCFB-VMT); Luzzi et al., 2007)
before entering the scanner to establish their visuospatial
memory baseline. Participants then performed a variation of the
Chimeric Face Test (CFT; Levy et al., 1983) that we created called
the ‘‘emotional valence determination task (EVDT)’’ while in the
scanner.
CDDAT patients were expected to perform as well as
or slightly worse than neurotypicals (NTs) on the EVDT.
Neuroimaging data was expected to show functional under-
activation within the frontal (inferior frontal; left middle
frontal) and parietal lobes (bilateral supramarginal gyri and left
precuneus), given their association with non-verbal emotional
processing, as well as increased activation of the bilateral
amygdala and right anterior cingulate cortex (r-ACC), reflecting
a greater reliance on these structures, during the EVDT
(Nakamura et al., 1999; Fusar-Poli et al., 2009). Likewise, we
hypothesized that DTI may show some deterioration of white
matter (WM) tracts within frontoparietal connections, but not
within amygdaloidal or cingulate tracts. Performance on the
EVDT was expected to correlate to ROCFB-VMT performance.
We hypothesized that this represents a relationship between
emotional valence determination and visuospatial memory.
By investigating the potential association of early-stage AD
neuroimaging findings and non-verbal skill performance, we
assessed the usefulness of these tests as cost effective supportive
diagnostic markers of AD.
As may be expected, most task-related studies of AD focused
on memory and displayed a pattern of early compensation
followed by decreased activity. Pariente et al. (2005) noted
increased activation during episodic memory encoding and recall
in the posterior cingulate cortex (PCC), precuneus, parietal lobe
and frontal lobe in early-stage AD patients with a mean Mini
Mental State Exam (MMSE) score of 25 ± 1.8. Grady et al.
(2003), Dickerson et al. (2005), Celone et al. (2006) and Zhou
et al. (2008), on the other hand, observed decreased or even
absent activation relative to NTs in the same regions in early-
stage AD patients with mean MMSE scores of 21.1± 3.1, 22± 5,
21.3 ± 2.7, respectively. These findings support the assertion of
Risacher and Saykin (2013) that increased activation occurs early
on in an attempt to compensate, but ultimately leads to decreased
activation once the disease burden is too great. We reasoned that
this pattern of initially increased activation leading to decreased
activation could be demonstrated for other cognitive domains
as well because it represents a fundamental mechanism of the
energetics of neurodegeneration. For a comprehensive review of
AD discoveries through neuroimaging see Risacher and Saykin
(2013).
Of equal importance is the understanding of how WM tracts
are affected by the disease.WM alterations appear to parallel gray
matter (GM) changes in that cortical abnormalities are greater in
posterior brain regions relative to anterior regions at the early-
stages of AD (Arnold et al., 1991; Braak and Braak, 1995). When
the disease progresses, the neurofibrillary pathology advances
from limbic to frontal structures, into higher-order association
cortices, and finally into primary sensorimotor areas, which
correlates with the clinical manifestations of AD (Braak and
Braak, 1995). DTI-based tractography studies (Fellgiebel et al.,
2005) and whole-brain DTI studies (Medina et al., 2006; Rose
et al., 2006; Zhang et al., 2007) have consistently shown that fibers
located deep in the posterior WM (e.g., the superior longitudinal
fasciculus (SLF) and the posterior cingulum bundle (PCB)) are
affected in patients with AD and mild cognitive impairment
(MCI), a common precursor to AD. Bartzokis et al. (2003, 2004)
have proposed that this may occur because as brain development
takes place, later myelinated regions (cortical association areas)
have fewer oligodendrocytes supporting greater numbers of
axons (Bartzokis, 2004). DTI findings of decreasedWM integrity
in later myelinated regions at the onset of AD support this
‘‘reversed demyelination’’ construct (Medina and Gaviria, 2008).
Furthermore, Huang et al. (2007) delineated a neuroanatomical
pattern of functional alterations showing that changes in WM
diffusion in parietal lobes correlated with scores of visuospatial
skills.
Research on amnestic type MCI (aMCI) populations using
neuropsychological tests of declarative memory extend this
trend as they have demonstrated significant correlations between
declining performance and decreases in posterior WM fractional
anisotropy (FA), particularly in the PCB (Fellgiebel et al.,
2005, 2008, Rose et al., 2006). Recalling the proposal of
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Bartzokis et al. (2004), disruptions in transcortical connectivity
may serve as early contributors to the pathophysiology of
dementia, as the observed WM deteriorations were embedded
beneath cortical GM that is often affected early within the disease
course. For a more in-depth review of DTI findings in AD, see
Medina and Gaviria (2008).
Although memory deficits are a hallmark characteristic of
AD, there may be little to gain from testing face-processing
related to familiarity that isn’t already known (Sperling et al.,
2003; Golby et al., 2005; Winchester, 2009; Donix et al.,
2013). On the other hand, the fundamentals of face-processing
(e.g., emotional valence) have received little attention (Job, 2012)
and warrant further investigation. The use of neuropsychological
tests in combination with neuroimaging techniques stresses the
importance of attempting to integrate pathological observations
with clinical symptoms. In doing so, we are able to reinforce
findings from either end of the spectrum to more efficiently
develop our understanding of the disease. In order to investigate
a cognitive operation as complex as face-processing, it will be
necessary to use appropriate tests that can isolate its specific
subdivisions. This is particularly important when performing an
fMRI investigation, as some studies suggest that face-processing
and recognition occurs in fractions of a second (Vuilleumier and
Schwartz, 2001; Batty and Taylor, 2003). If such factors are not
properly accounted for, it would be very difficult to remove these
confounds from the fMRI data as the canonical hemodynamic
response curve peaks between 4–6 s after the presented stimuli,
making it far too slow to tease out these processes (Poldrack et al.,
2011).
To this end, the EVDT was of particular value since it is
a variation of the CFT. The CFT was originally developed by
Levy et al. (1983) ‘‘to index functional cerebral asymmetry for
processing facial characteristics.’’ It was shown to be highly
reliable in detecting differences between right- and left-handers
as well as being stable with regard to individual differences in
perceptual asymmetries (Levy et al., 1983).
CFTs have previously been used to investigate asymmetries
in the processing of emotions from facial expressions. Early
works by Albert et al. (1991) and Cadieux and Greve (1997)
suggested that by the moderate-stage, AD patients were impaired
in recognizing emotions, but the authors noted that they could
not rule out confounds ‘‘due to the deficits in recognizing
non-emotional facial features and in verbal processing’’. Roudier
et al. (1998) demonstrated thatmoderate-stage AD patients could
accurately recognize when different emotions were displayed
using the same human face. Hargrave et al. (2002) reconciled
this difference through the use of a ‘‘same-different’’ emotion
differentiation task in which participants were presented with a
pair of photographs of different people and were asked to state
if the two photographs in the pair were depicting the same or
different emotions. From this, it was determined that moderate-
stage AD patients do, in fact, have difficulty differentiating
emotions independent of verbally-mediated and non-emotional
facial features. Indersmitten and Gur (2003) then determined
that two separate circuits likely underlie emotional processing
in facial asymmetries and, while the left hemiface/right cerebral
hemisphere circuit was dominant for expressions of sad, fearful
and happy, the right hemiface/left cerebral hemisphere proved to
be more efficient on task performance in NTs.
Then, Luzzi et al. (2007) used a variation of the CFT
called the Mona Lisa test (MLT) wherein they determined that
when using a cartoon face, emotional valence determination
was impaired in some participants with moderate-stage AD,
but not significantly across the entire cohort. Luzzi et al.
(2007) found that in those with impaired recognition of facial
emotions, the impairment correlated to poor performance on
constructional praxis and non-verbal memory test, but not to
the verbal fluency test (VFT) or MMSE score. Therefore, the
ability to recognize facial emotions correlated to non-verbal
performance. Finally, a fMRI meta-analysis by Fusar-Poli et al.
(2009) discovered that the processing of facial expressions for
emotional valence was associated with neural activation in the
parietal and frontal cortices in NTs, thereby making these ideal
regions of interest for investigation of the emotional subdivision
of face-processing.
All things considered, we chose to use a ‘‘same-different’’
task similar to Hargrave et al. (2002) to observe changes
in brain activity and connectivity in early-stage CDDAT
patients as it represents the most clinically relevant task given
its translatability to real life scenarios. Their work did not
incorporate neuroimaging techniques, however, representing a
gap in knowledge which we intended to fill with the current
study. The works of Roudier et al. (1998), Indersmitten and
Gur (2003), Luzzi et al. (2007) and Fusar-Poli et al. (2009)
established crucial observations that were necessary to proceed
in such a manner as without them there would be too many
potential confounds to consider using depictions of actual
human faces, let alone a series of different faces, to assess
emotional processing through neuroimaging. Additionally, by
using non-chimeric variations of faces based on the Mattingley
et al. (1993) chimeric faces, we more directly assessed the
emotional valence components of face-processing than we could
through the original CFT.
The ROCFB served as an ideal cognitive test for
investigating the non-verbal underpinnings of emotional
valence determination because it had been described by Luzzi
et al. (2011) to be ‘‘a valid instrument to assess non-verbal
memory in adults and in the elderly’’. Building upon the findings
of Luzzi et al. (2007), we investigated the relationship between
the ROCFB-VMT and the EVDT. We assessed the potential
relationship between visuospatial memory (as measured by the
ROCFB-VMT) and the EVDT to determine if the ability to
discern emotional states from facial expressions is rooted in
the brain’s ability to recognize and retain visuospatial relations
between shapes.
MATERIALS AND METHODS
Participant Identification and Selection
The University Medical Center Departments of Neurology,
Family Medicine, and Geriatrics saw 171 patients for complaints
of ‘‘memory problems’’ or ‘‘dementia’’ spanning a 6-month
period (November 2015–April 2016). Potential participants were
identified and classified into their respective categories by
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physician assessment. Of that, 100 were determined to have
AD or its precursor, aMCI, in accordance with the guidelines
outlined by McKhann et al. (2011) for ‘‘dementia due to AD’’
or ‘‘MCI due to AD’’ (Albert et al., 2011). Those in the possible
early-stage AD category were selected based on an MMSE score
(Folstein et al., 1975) of 26–21 in accordance with National
Institute for health Care and Excellence guidelines (National
Institute for Health and Care Excellence, 2011). Twenty of these
patients were determined to fit our inclusion/exclusion criteria,
four of whom agreed to participate. All CDDAT participants had
an existing medical MRI scan interpreted by a radiologist within
the last 5 years prior to the study. These individuals were grouped
into the CDDAT group. Detailed inclusion/exclusion criteria for
the CDDAT group are listed below:
Inclusion criteria
• The diagnosis of AD was made in line with international
diagnostic criteria (Albert et al., 2011; McKhann et al.,
2011) on the basis of clinical history, neurologic, psychiatric,
neuropsychological evaluation and hematologic screening
for dementia (including liver and kidney function, thyroid
function, folic acid and B12 vitamin levels, neoplastic
markers), electroencephalogram, carotid ultrasonography,
and neuroimaging studies (computed tomography and/or
magnetic resonance) as determined by the attending
physician.
• Mean general cognitive decline was evaluated with the MMSE
(Folstein et al., 1975).
• All participants gave their informed consent to participate in
the study.
Exclusion criteria
• Inability to understand the instructions from the principal
investigator (PI) or research conductors.
• History of substance abuse.
• History of neurological deficits not related to AD.
• Inability or refusal to give informed consent.
• Motor, visual, or hearing impairment that precluded ability to
perform cognitive testing assessments.
• Failure to pass the MRI safety checklist guidelines.
Ten age-matched cognitively normal participants (5 males,
5 females) were recruited from a nearby senior living center
and were grouped into the NT group. NTs were required
to have an MMSE score >27 and meet all inclusion and
exclusion criteria stated above, except for that concerning the
existence of Alzheimer-related pathology. One male participant
was retroactively removed after receiving a diagnosis of normal
pressure hydrocephalus. One female participant from the
NT group was removed due to a scanner script runtime
error that prevented the EVDT from being run. Therefore,
there were 4 CDDAT (1 female, 3 males) and 8 NT
(4 females, 4 males) participants in this study. All participants
were right-handed, except for 1 non-right-hand-dominant
NT female, as confirmed by the Edinburgh Handedness
Inventory-revised (EHI-r; Williams, 1986). The non-right-
hand-dominant NT female that was kept in the study
was kept because the participant was shown to have no
significant difference in either their accuracy, reaction time
(RT), or within-group contrast mapping for either fMRI or
DTI measures when compared to the rest of the control
group.
Participants were informed that their participation was
voluntary and they may withdraw from the study at any time and
that their refusal to participate would have no impact on their
level of care. This study was carried out in accordance with the
recommendations of Texas Tech University Human Protections
Internal Review Board with written informed consent from
all subjects. All subjects gave written informed consent in
accordance with the Declaration of Helsinki. The protocol study
was approved by the Texas Tech University Human Protections
Internal Review Board.
Sample Size
A 2004 meta-analysis by Henry et al. (2004) demonstrated an
effect size of r = 0.73 for a test of semantic fluency in patients
with Dementia of the Alzheimer Type (DAT). From this it was
determined that an assumed effect size of r = 0.8 would achieve
80% power with a minimum sample size of 4. Our behavioral
analyses, therefore, seek to determine if an impairment on either
the EVDT or ROCFB-VMT is greater than or equal to the known
deficit of verbal fluency, as this currently represents the most
consistent and pronounced clinical manifestation of the disease
at this stage. Effect size for each test was calculated using Cohen’s
d and converted to its r-equivalent (Cohen, 1992).
The number of necessary participants was based on the
Desmond and Glover (2002) report that single voxel-level power
of 80%, corrected for multiple comparisons can be achieved with
a sample size of 24 per group. According to Desmond and Glover
(2002), ‘‘Sample size increases power because the standard error
of the mean decreases by the square root of N’’ (N = the number
of subjects). In our study, we had a minimum of four subjects
within each group. Therefore, we may expect to reach of 32.7%
power at the single voxel level (i.e., since we have 1/6 of the
number of subjects we will reach 41% of the power achieved
by having 24 per group or 33% overall; the square root of
4/24 = 0.41∗0.8 = 0.328). As such, even by the most conservative
of estimates (assuming a power of 10 exponential) our minimum
detection for 80% power is 316 voxels (80%/32%= 2.5; 102.5=
316). Given that this is a region-of-interest-based investigation
(ROI) >1000 voxels, however, we may reasonably expect to
surpass 80% power for each ROI with a sample size of ≥4 per
group.
Participant Demographics
Participant demographics are summarized in Table 1. We
recruited four right-handed Caucasian patients (3 males,
1 female) with a diagnosis of aMCI or early-stage AD between
the ages of 73–93 (median age 83.5 ± 8.4) with MMSE scores
between 26–23 (median of 24.5± 1.3). Two of the males (MMSE
scores of 26 and 25) had an existing diagnosis of ‘‘MCI due
to AD’’ (Albert et al., 2011). The remaining male and female
had an existing diagnosis of ‘‘dementia due to AD’’ (MMSE
scores of 24 and 23, respectively; McKhann et al., 2011). Eight
(7 right-handed and 1 non-right-hand-dominant) cognitively
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TABLE 1 | Participant demographics.
Group Age (median ± stdev) Sex Handedness Race MMSE (median ± stdev)
CDDAT (n = 4) 83 ± 8 1 F, 3 M 4 R 4 CA 24.5 ± 1.3
NT (n = 8) 80 ± 4 4 F, 4 M 7 R, 1 nR 8 CA 30 ± 0
CDDAT, clinically diagnosed dementia of the Alzheimer type; NT, neurotypical; F, female; M, male; R, right-handed; nR, non-right-handed; CA, Caucasian.
normal Caucasian participants (4 males, 4 females; all with
MMSE scores of 30) between the ages of 79–91 (median age
80 ± 4.0) also participated. Handedness was determined using
the EHI-r (Williams, 1986).
There was no significant difference in median age (p = 0.561),
but there was an observable difference in median MMSE score
for the two groups (p = 0.014). While there may be some concern
given our lack of equal sex-distribution (1 female and 3 males)
within the CDDAT group, no differences in performance were
discernable based on sex within our NT group (4 females,
4 males) across either cognitive test (ROCFB-VMT or EVDT)
for either accuracy or RT (data not shown) nor for within-
group sex-based contrast mapping for fMRI or DTI (data not
shown).
Administration of Rey Osterrieth Complex
Figure B Visuospatial Memory Test
Participants were first asked to copy the ROCFB as accurately as
possible, without tracing it, on a different sheet of paper that had
the same dimensions as the paper containing the figure. The size
of the model was 5.5 cm× 8 cm, and the sheet of paper on which
it was printed was half the size of an 8.5′′× 11′′ sheet. Participants
were then asked to reproduce the ROCFB from memory on a
different sheet of paper after an interval of 5 min, during which
they were engaged with the VFT (Luzzi et al., 2007). The rate
of retention was calculated as a percentage of the score obtained
on reproduction from memory compared to the original figure-
copying score. Digital photographs were taken of the drawings
produced by participants to ensure accuracy of scoring. The test
was administered and scored following the protocol detailed in
Luzzi et al. (2011).
Imaging Methodology and Analyses
Stimulus Presentation and Participant Response
After completing the ROCFB-VMT, all participants were briefly
trained on the EVDT before entering the scanner to ensure task
comprehension by allowing them to practice on a single example
trial of each condition type. Pairs of faces based on the chimeric
faces of Mattingley et al. (1993) were presented in an event-
related design for the EVDT using Eprime 2.0. Presentation order
was counterbalanced across participants using a Latin square
design. The question ‘‘Are the emotions the same?’’ was displayed
upon the screen for 4 s inside the scanner. A set of 40 trails were
randomized and displayed for 4 s (s) each with a jittered inter-
stimulus interval (ISI) randomized for five time points between
800–1200 ms, by 100 ms apiece. Participants responded using a
fiber optic controller held in the right hand where button 1 was
pressed by the index finger and button 2 was pressed by the
middle finger. Participants pressed one of two buttons to indicate
Yes (button 1) or No (button 2) in response to the question. An
example of this test is given in Figure 1.
Scanning Parameters
All images were acquired with a 3T Siemens MR system (Skyra,
Germany) at the Texas Tech Neuroimaging Institute. The
T1 anatomic scan parameters were: TR: 1900 ms; TE: 2.49 ms;
FOV: 240; Flip angle: 9, Voxel size = 0.9 × 0.9 × 0.9 mm;
slice number: 192. The fMRI parameters were: TR:
2500 ms; TE: 20.0 ms; FOV: 231; Flip angle: 75, Voxel
size = 2.5 × 2.5 × 3.0 mm; slice number: 41. In each fMRI
dataset, there are 80 volumes. The DTI parameters were:
TR: 5000 ms; TE: 95 ms; FOV: 220; B/W: 1562, Voxel
size = 1.7 × 1.7 × 4.0 mm; slice number: 32. There were
64 directions for DTI.
Image Preprocessing
fMRI
Image preprocessing steps included removing non-brain
structures by Brain Extraction Tool (BET), motion correction
by using Motion Correction for FSL Linear Registration Tool
(MCFLIRT), temporal high-pass filtering with a cutoff period
of 24 s, spatial smoothing with a 5 mm Gaussian full width,
half maximum (FWHM) algorithm, and co-registering of the
functional images to the high resolution T1 structure images
in their native space using boundary border registration (BBR)
and FSL Linear Registration Tool (FLIRT; Jenkinson and Smith,
2001; Jenkinson et al., 2002) at 12 degrees of freedom to the
Korean Normal Elderly (KNE96; Lee et al., 2016) standard brain
space.
DTI
FSL Diffusion Toolbox 3.0 (FDT) from FMRIB Software Library
(FSL 5.0.5) was used to complete the construction of and
preprocessing for all anatomical brain networks for all subjects.
It processed DICOM/NIfTI files into diffusion metrics (e.g., FA)
that were ready for statistical analysis at the voxel-level after
performing corrections for image alignment and artifact clean-up
(Top-Up) and local field distortions (eddy current correction;
Smith et al., 2004).
Image Processing
fMRI
fMRI data processing was carried out using FMRI Expert
Analysis Tool (FEAT)Version 6.00, part of FSL1 (Worsley, 2001).
The time series for the behavioral events of the EVDT were
analyzed for the following conditions:
1www.fmrib.ox.ac.uk/fsl
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FIGURE 1 | Examples of the emotional valence determination test (EVDT). EVDT examples in response to the question: “Are the emotions the same?” (left)
“yes”; two neutral faces. (center) “yes”; two happy faces. (right) “no”; happy (top) and neutral (bottom).
For ‘‘presentation of stimuli scenarios’’ (i.e., when the
participant was shown two happy faces, two neutral faces, or
one of each)—brain activity from the first 2 s following the
presentation of a stimulus was recorded for each trial. In the
event a participant responded within <2 s, the interval between
the presentation of the stimulus and 250 ms before the response
was used for the recording interval. This was done to avoid brain
activity artifacts related to the button press. Instances where a
participant made no response before the presentation of the next
stimulus were discarded.
For ‘‘participant response’’ scenarios (i.e., when the
participant chose ‘‘yes’’ (y) or ‘‘no’’ (n) in response to the
question: ‘‘Are the emotions the same?’’)—brain activity from
the first 2 s following the press of a button was recorded for each
trial. In the event a participant responded within <2 s before the
presentation of the next stimulus, that interval was used for the
recoding time. Instances where a participant made no response
before the presentation of the next stimulus were discarded.
A summary of fMRI contrasts is given in Table 2. A total
of five subject-level contrast maps were created for all subjects
using threshold free cluster enhancement (TFCE) of z > 2.3 and
TABLE 2 | Summary of functional magnetic resonance imaging (fMRI)
contrasts.
Task type Option 1 Option 2 Option 3
EVDT-presentation of
stimuli:
Two happy faces Two neutral faces One of each
EVDT-choice of the
participant:
Yes No –
A total of five subject-level contrast maps were created for all subjects. EVDT,
emotional valence determination test.
a cluster corrected significance threshold of p < 0.05. These
modeled time series were convolved with the double gamma
hemodynamic response function (dg-HRF), which was modeled
from a combination of Gaussian functions. Group-level contrast
maps were created using FMRIB’s Local Analysis of Mixed
Effects (FLAME1). The thresholds for group level activation
maps were created using TFCE of z > 1.5 and a cluster-
corrected significance threshold of p < 0.05. The exact regions
of brain activity were determined using the KNE96 coordinate
space and Harvard-Oxford cortical and subcortical structural
atlases.
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DTI
Voxel-based group differences were calculated for the FA
images using Tract-Based Spatial Statistics (TBSS; Smith et al.,
2006; Smith and Nichols, 2009; Cheon et al., 2011). TBSS
linearly registered individual FA images in native space
and then to the FA template via the FLIRT command
of FSL. The resultant warping transformations were then
used to convert images of diffusion (i.e., FA) to Montreal
Neuroimaging Institute (MNI152) space with a spatial resolution
of 1 × 1 × 1 mm. For statistical inference, including correction
for multiple comparisons, permutation testing was used (Nichols
and Holmes, 2002; Cheon et al., 2011) as implemented by
RANDOMISE of the FSL software package. Five hundred
permutations were performed for significant group differences
at a threshold of 0.2; corresponding to p < 0.05, corrected
for multiple comparisons using TFCE (Smith and Nichols,
2009; Cheon et al., 2011). WM tracts were identified using
the Johns-Hopkins University ICBM-DTI-81 WM labels and
probabilities of tract accuracy were assessed using the Johns-
Hopkins University WM Tractography atlas.
Behavioral Methodology and Analyses
All statistical calculations for behavioral analyses were performed
using Rstudio Desktop (version 0.99.896, Rstudio, Inc., Boston,
MA, USA).
Comparison of Test Performance Amongst Study
Groups
Mann-Whitney U-tests with false discovery rate corrections of
α = 0.05 for multiple comparisons to reach significance at
p < 0.05 were used to evaluate differences in test performance
between the study groups. A one-sample t-test with mu = 30 and
two-sample U-test were used to calculate the group difference
in MMSE score given that the variance for the NT group was
zero. Both tests revealed a significant result. Additionally, the
zero variance for the NT group on the MMSE is within reason
for cognitively normal elderly individuals, as persons without
cognitive deficits may be expected to receive a perfect score
(30/30) as was seen here (Folstein et al., 1975).
Correlation of CFTs to Cognitive Test Performance
Pearson correlation coefficients, with false discovery rate
corrections of α = 0.05 for multiple comparisons to reach
significance at p< 0.05, were used to correlate CFT performance
to performance on their respective cognitive tests.
Assessing Tests as Classifiers
Fischer Exact test, with corrections for multiple comparisons of
α = 0.05 to reach significance at p< 0.05, were used to determine
strength of each test as a classifier between CDDAT and NT.
RESULTS
Behavioral Data
We found no significant difference in median ROCFB-VMT
or EVDT score for the two groups (NT = 58 ± 26.2
FIGURE 2 | (A) Results of Rey-Osterrieth Complex Figure B-Visuospatial
Memory Test (ROCFB-VMT) and EVDT. (B) ROCFB-VMT and EVDT
performance were not correlated Pearson Correlation r = 0.022,
pcorrelation = 0.648. NT, Neurotypicals; CDDAT, Clinically diagnosed dementia of
the Alzheimer Type.
vs. CDDAT = 41± 23.6; Cohen’s d =−0.196, r-equivalent effect
size = −0.0975, p = 0.555, NT = 85 ± 8.8 vs. CDDAT = 87 ± 13;
Cohen’s d = 0.671, r-equivalent effect size = 0.318, p = 0.969,
respectively). There was also no significant different RT for the
EVDT (CDDAT = 2166 ± 461 ms vs. NT = 2084 ± 493 ms, not
shown). Therefore, neither ROCFB-VMT nor EVDT function
as a potential classifier between NT and CDDAT given their
nearly identical overlap. All of these findings suggest that no
observable difference in either emotional valence determination
or visuospatial ability exists between these two groups at this
stage of the disease. Additionally, we found no correlation
between the ROCFB-VMT and EVDT performance (R2 = 0.022,
p = 0.648). Thus, at this stage of the disease there appeared
to be no connection between emotional valence determination
ability and visuospatial memory decline; this finding, however,
may be the result of a ceiling effect in participant performance.
Behavioral results are summarized in Figure 2.
Imaging Results
fMRI Results
There were no significant differences in areas of activation
between groups upon stimulus presentation regardless of the
emotional pairing displayed (data not shown). Furthermore, no
differences in areas of activation were observed between groups
with relation to when they chose ‘‘yes’’ or ‘‘no’’ in response to
the question: ‘‘Are the emotions the same?’’, thus indicating no
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fundamental difference in perception or processing of the faces
(data not shown).
DTI Results
CDDAT did not show higher FA values in any areas. NTs showed
higher FA values than CDDATS in the right inferior longitudinal
fasciculus (r-ILF), right posterior thalamic radiations (r-PTR)
and the bilateral PCC (b-PCC) and superior longitudinal fasciculi
(b-SLF). For the SLF, the differences between NTs and CDDATs
were greater in the left than the right hemisphere, suggestingWM
deterioration has occurred in the CDDAT group. No significant
differences were observed in any of the three major amygdala
connection pathways: the amygdalofugal, the stria terminalis,
or the anterior commissure. Imaging results are summarized in
Figure 3.
DISCUSSION
Significance of Behavioral Findings
Consistent with our hypothesis and the previous findings of
Albert et al. (1991) and Luzzi et al. (2007), CDDAT participants
displayed no difference in accuracy or RT for either the
ROCFB-VMT or the EVDT. These findings support the notion
that non-verbal abilities, as measured by the ROCFB-VMT, and
emotional valence determination, as measured by the EVDT, are
largely intact in early-stage AD patients.
All of the subjects were combined together when analyzing
the correlation of CFTs to cognitive test performance. Although
it would be possible to add a categorical variable representing
disease/no disease to the model to generate a multivariate linear
model that controls for disease status, that would be ideal if the
goal was to produce the most predictive model or if we were
trying to demonstrate the causal dependence of the dependent
variable on the independent variable.
However, there are several reasons we chose not to control
for disease status. First, in principle, people who might apply
these tests would likely not know disease status prior to
administration. Thus, a model that controls for a variable
that they don’t have available might confuse its application.
Second, we are not proposing that CFT is causing cognitive
test performance so much as they are simply correlated; that
is, our goal is not necessarily to construct the most explanatory
possible model. Controlling for disease status makes that
impossible.
FIGURE 3 | Pertinent diffusion tensor imaging (DTI) results for the EVDT. Significant differences were seen in the posterior cingulate cortex (PCC; light blue
crescent, top) and superior longitudinal fasciculi (blue crescent, bottom), but not anterior cingulate (red crescent, top) or amygdaloidal connections (pink circle,
bottom). Areas where NT > CDDAT for fractional anisotropy (FA) measures are shown in red. Green lines represent the FA skeleton. NT, Neurotypicals; CDDAT,
Clinically Diagnosed Dementia of the Alzheimer Type.
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Significance of fMRI Findings
Further support for our hypothesis comes from the fMRI results.
We hypothesized that, in the absence of differences in behavioral
performance, there would likely be no difference in brain activity.
We also hypothesized that, if such a difference were seen, it would
occur within the parietal lobes, amygdalae, or r-ACC based on
fMRI findings in NTs reported by Fusar-Poli et al. (2009). The
lack of differences between the brain activity patterns of the two
groups upon stimulus presentation and during the selection of
a response suggests that early-stage AD patients perceive the
stimuli and choose a response in a fundamentally similar way to
NTs, thereby strengthening the notion that these processes are
not yet demonstrably affected by the disease.
Significance of DTI Findings
Although our behavioral and functional imaging results seem
promising with regard to the retention of non-verbal skill
sets, a more concerning observation was made through DTI.
Consistent with our hypothesis, we saw lower FA values in the
b-SLF, especially within the left hemisphere, and b-PCC, but
no differences in the amygdalae or r-ACC. While there were
no significant differences in the major amygdala or anterior
cingulate connection pathways, the changes in the SLF and the
PCC are consistent with both the pathological progression of
WM deterioration in AD (Braak and Braak, 1997; Bartzokis,
2004; Leech and Sharp, 2014) and proposed mechanisms of
emotional valance (Maddock et al., 2003; Fusar-Poli et al., 2009).
In congruence with Indersmitten and Gur (2003), we propose
the greater deterioration of the left-SLF tracts observed herein
suggests a decline in processing efficiency for emotion, but a
retention of the dominant circuit, which is served by tracts of
the right-SLF. Finally, Kosaka et al. (2003) determined that the
PCC plays an important role in face-processing for the transition
of a face from being unrecognized to being acknowledged as
familiar in NTs. Therefore, the early deterioration of PCC
connecting fibers may play a significant role in AD patients’
impaired ability to recognize loved ones independent of semantic
memory loss. Taken together, our findings further support the
reverse demyelination hypothesis, proposed by Medina and
Gaviria (2008), and Bartzokis’s (2004) assertion of the role of
myelin damage predating neuronal loss and its possible role in
exacerbating the progression of AD.
Limitations
We acknowledge that the instances in which our behavioral
analyses did not find a significant difference between our NT and
CDDAT groups does not necessarily mean that impairments are
not present at this time. Instead, it indicates that such deficits, if
they exist, are less severe than those of semantic verbal fluency,
which currently represents the most consistent and pronounced
clinical manifestation of this disease at this stage (Henry et al.,
2004). Additionally, the perfect score with zero variance obtained
on the MMSE by our control group makes them an idealized
group for comparison, but it also makes them less representative
of the NT geriatric population as a whole. It is important to note,
however, that they were not intentionally selected to obtain a
perfect score and that this is an incidental result.
As previously mentioned, the inability to directly correlate
ROCFB-VMT: EVDT performancemay be due to a ceiling effect.
Replicating this experiment with a more difficult visuospatial
test, such as the Rey Osterrieth Complex figure A (ROCFA) may
result in an observable difference between NTs and early-stage
CDDAT, but given that a similar correlation has been established
for the MLT and ROCFB in moderate-stage AD by Luzzi et al.
(2007) such an observation may be more academic than clinically
relevant.
It is important to note, however, that since the etiology of
AD is unknown and requires post mortem confirmation it is
possible that our findings may not extend to all individuals
affected with the ailment. Other potential cofounders could be
differences in the demographics and comorbidities in the two
groups. Due to restrictions related to the approved Human
Protections Board protocol, we do not have any additional
medical or demographic information (e.g., marital status, list
of medications or medical comorbidities that are not of a
neurologic or psychiatric nature) on our participants than
what is currently described. An alternative interpretation is
that although there is significant structural damage, the lack
of functional differences between the groups may represent
a type of structural compensation independent of reverse
demyelination. Conversely, these observations may be rooted
in fundamental issues of neurodegeneration and may therefore
extend to other neurodegenerative diseases making these
findings simultaneously of larger interest to the field as a
whole, but less exclusive to AD. Additional investigations will be
necessary to access the reproducibility of these findings in other
populations as well as their specificity to AD.
CONCLUSION
While we observed that both groups performed similarly on
both skill sets, we found no correlation between the two,
due in part to the massive variations in ROCFB-VMT scores.
Yet, since both groups scored within normative ranges after
adjusting for age and education (Becker et al., 1987), we conclude
that both skill sets are intact within these participants at this
stage of the disease. Furthermore, there were no significant
differences in BOLD fMRI activation with regard to either
stimulus presentation or participant response, strengthening our
assertion that these skill sets are, as of yet, unaffected. Lastly,
these findings are consistent with the previous work by Luzzi
et al. (2007). The deterioration of WM tracts within the b-SLF
and b-PCC may foreshadow the impending decline of these
functions, as would be consistent with clinical observations
(Moore and Wyke, 1984; Haupt et al., 1991; Liu et al., 1991) and
autopsy findings (Braak and Braak, 1997) for the progression of
the disease.
In conclusion, our discoveries highlight the potential of WM
tractography as a presymptomatic biomarker for AD. Based on
our observations we suggest that when caring for patients with
suspected early-stage AD, use direct/pronounced body language
and facial expressions over verbal commands whenever possible.
Emphasizing non-verbally mediated social cues has the added
benefit of strengthening social interaction, which may help slow
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the progression of symptoms (Bennett et al., 2006) and reduce
the risk of depression (Yaffe et al., 1999).
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